Basilea Pharmaceutica
BSLN.SW
#6328
Rank
HK$4.89 B
Marketcap
HK$403.62
Share price
2.38%
Change (1 day)
13.88%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2023: HK$8.03

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is HK$8.03. In 2023 the company made an earnings per share (EPS) of HK$8.03 a decrease over its 2022 EPS that were of HK$8.57.

EPS history for Basilea Pharmaceutica from 2002 to 2023

Annual EPS

Year EPS Change
2023HK$8.03-6.28%
2022HK$8.57-273.94%
2021-HK$4.93-60.87%
2020-HK$12.59-24.46%
2019-HK$16.66-26.92%
2018-HK$22.8059.83%
2017-HK$14.26-63.06%
2016-HK$38.62-19.26%
2015-HK$47.8346.12%
2014-HK$32.7310.07%
2013-HK$29.73-36.76%
2012-HK$47.02-5.42%
2011-HK$49.71-153.36%
2010HK$93.16-198.47%
2009-HK$94.60-15.34%
2008-HK$111.7416.7%
2007-HK$95.7536.07%
2006-HK$70.3779.07%
2005-HK$39.30-46.79%
2004-HK$73.859.83%
2003-HK$67.24-34.23%
2002-HK$102.23